MedTrace Logo

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

NCT05309499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2026-01-05

Study results available
· View outcomes & findings →

Summary

The OPERA-MI trial evaluates the effect of i.v. ferric carboxymaltose compared to the effect of oral iron, on left ventricular systolic function.

Conditions

Interventions

DRUG

ferric carboxymaltose

ferric carboxymaltose is i.v. iron, 99 patiants will be randomised to this group

DRUG

ferrous sulphate

ferrous sulphate is oral iron, 100 patiants will be randomised to this group

Sponsors & Collaborators

  • Kazan State Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-05
Primary Completion
2025-09-15
Completion
2025-09-15

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309499 on ClinicalTrials.gov